The South-East Asia Region including India, reported the highest number of cancers of lips and oral cavity, uterine cervix, ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer ...

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

The EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial ...

Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

The European Commission approves GSK's Jemperli plus chemotherapy to treat all adult patients with primary, advanced or recurrent endometrial cancer.

GSK (GSK) has received expanded approval from the European Commission for its drug Jemperli, also known as dostarlimab, in the treatment of endometrial cancer. Read more here.

London: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy ...

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

This has been linked to lifestyle changes, metabolic diseases, and obesity, with cases increasingly being reported in women ...